Skip to main content

Table 1 Associations of rs9984273 C allele* to disease severity of COVID-19 in meta-analyses

From: Polymorphism in interferon alpha/beta receptor contributes to glucocorticoid response and outcome of ARDS and COVID-19

Phenotype of cases and controls (database release)

Number of cases with genotype information

Number of controls with genotype information

Odds Ratio (95% confidence interval)

P value

Number of studies

P value from Cochran's Q heterogeneity test

Very severe respiratory confirmed covid vs. not hospitalized covid (release 4)

269**

688*

0.69 (0.46–1.02)

0.065

3

0.469

Very severe respiratory confirmed covid vs. general population (release 6)

6321

678,513

0.93 (0.89–0.98)

0.006

19

0.759

Hospitalized covid vs. not hospitalized covid (release 6)

13,582

66,291

0.96 (0.93–1.00)

0.035

20

0.313

Hospitalized covid vs. general population (release 6)

19,876

1,450,704

0.96 (0.93–0.98)

0.001

33

0.291

Covid vs. general population (release 6)

95,644

1,752,242

0.99 (0.98–1.00)

0.048

60

0.318

  1. *The patients with CC/CT vs TT were compared
  2. **Total number of cases and controls. Subjects involved in the calculation were 679 (distribution of cases and controls used in the calculation was not given in the original data)